Quantcast
Pfizer, BioNTech to seek FDA approval for booster shots for 16 and 17-year olds- Washington Post - Metro US

Pfizer, BioNTech to seek FDA approval for booster shots for 16 and 17-year olds- Washington Post

Families to reunite for holidays after COVID vaccinations for children ages 5-11

(Reuters) – Pfizer Inc and German partner BioNTech SE are expected to ask the U.S. Food and Drug Administration in the next few days to authorize their COVID-19 vaccine booster shot for 16 and 17-year olds, the Washington Post reported on Monday, citing two people familiar with the matter.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)

More from our Sister Sites